The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic factors for metastatic colorectal cancer with and without bevacizumab therapy.
Ikenna Osuorji
No relevant relationships to disclose
Greg Dyson
No relevant relationships to disclose
Durga Yerasuri
No relevant relationships to disclose
Philip Agop Philip
No relevant relationships to disclose
Anthony Frank Shields
No relevant relationships to disclose
Minsig Choi
No relevant relationships to disclose